139 related articles for article (PubMed ID: 37779083)
1. Adjuvant treatments for locally advanced differentiated thyroid cancer: a nationwide survey in Japan.
Kawamoto T; Yasuda K; Ito Y; Zenda S; Sakanaka K; Shikama N; Nakamura N; Mizowaki T
Endocr J; 2023 Oct; 70(10):999-1003. PubMed ID: 37779083
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
3. Propensity score matching analysis of adjuvant external-beam radiotherapy for the treatment of papillary thyroid carcinoma with other organ invasions.
Kawamoto T; Shikama N; Fukumori T; Hoshi M; Yamada T
Endocrine; 2023 Jun; 80(3):589-599. PubMed ID: 36600104
[TBL] [Abstract][Full Text] [Related]
4. External-beam radiotherapy for differentiated thyroid cancer locoregional control: A statement of the American Head and Neck Society.
Kiess AP; Agrawal N; Brierley JD; Duvvuri U; Ferris RL; Genden E; Wong RJ; Tuttle RM; Lee NY; Randolph GW
Head Neck; 2016 Apr; 38(4):493-8. PubMed ID: 26716601
[TBL] [Abstract][Full Text] [Related]
5. The role of external beam radiation therapy in the management of thyroid carcinomas: A retrospective study in Iran Cancer Institute.
Esmati E; Aleyasin A; Ghalehtaki R; Jafari F; Farhan F; Aghili M; Haddad P; Kazemian A
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1652. PubMed ID: 35691611
[TBL] [Abstract][Full Text] [Related]
6. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
Watanabe K; Igarashi T; Uchiyama M; Ojiri H
Ann Nucl Med; 2020 Dec; 34(12):920-925. PubMed ID: 32940889
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer.
Chen PV; Osborne R; Ahn E; Avitia S; Juillard G
Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515
[TBL] [Abstract][Full Text] [Related]
8. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
[TBL] [Abstract][Full Text] [Related]
9. A risk-adapted approach to the use of radioactive iodine and external beam radiation in the treatment of well-differentiated thyroid cancer.
Tuttle RM; Rondeau G; Lee NY
Cancer Control; 2011 Apr; 18(2):89-95. PubMed ID: 21451451
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis.
Dicuonzo S; Pedretti S; Mangoni M; Monari F; Fanetti G; Borsatti E; Lombardi D; Vianello F; Iacobone M; Corvò R; Magrini SM; Pappagallo G; Arcangeli S; D'Angelillo RM
Tumori; 2021 Dec; 107(6):489-497. PubMed ID: 33722108
[TBL] [Abstract][Full Text] [Related]
11. Is surgical resection without radioactive iodine treatment a safe alternative treatment for T1-2N1bM0 papillary thyroid carcinoma?
Fujiwara T; Yoshizawa A; Mizuta M; Tamaki H
Auris Nasus Larynx; 2021 Feb; 48(1):148-153. PubMed ID: 32718811
[TBL] [Abstract][Full Text] [Related]
12. The role of external beam radiotherapy in the treatment of papillary thyroid cancer.
Lee N; Tuttle M
Endocr Relat Cancer; 2006 Dec; 13(4):971-7. PubMed ID: 17158749
[TBL] [Abstract][Full Text] [Related]
13. Acute toxicity of adjuvant radiotherapy in locally advanced differentiated thyroid carcinoma. First results of the multicenter study differentiated thyroid carcinoma (MSDS).
Schuck A; Biermann M; Pixberg MK; Müller SB; Heinecke A; Schober O; Willich N
Strahlenther Onkol; 2003 Dec; 179(12):832-9. PubMed ID: 14652672
[TBL] [Abstract][Full Text] [Related]
14. External beam radiation therapy for recurrent or residual thyroid cancer: What is the best treatment time and the best candidate for long-term local disease control?
Cavalcante LBCP; Treistman N; Gonzalez FMTT; Fernandes PIW; Alves Junior PAG; Andrade FA; Ferreira EN; Brito TF; Pane A; Corbo R; Erlich F; Bulzico DA; Vaisman F
Head Neck; 2024 Jun; 46(6):1340-1350. PubMed ID: 38445804
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant radioactive iodine use among differentiated thyroid cancer patients in the military health system.
Gill AA; Enewold L; Zahm SH; Shriver CD; Zheng L; McGlynn KA; Zhu K
Mil Med; 2014 Sep; 179(9):1043-50. PubMed ID: 25181724
[TBL] [Abstract][Full Text] [Related]
16. External Beam Radiotherapy for Medullary Thyroid Cancer Following Total or Near-Total Thyroidectomy.
Jin M; Megwalu UC; Noel JE
Otolaryngol Head Neck Surg; 2021 Jan; 164(1):97-103. PubMed ID: 32746731
[TBL] [Abstract][Full Text] [Related]
17. Effect of prophylactic central compartment neck dissection on serum thyroglobulin and recommendations for adjuvant radioactive iodine in patients with differentiated thyroid cancer.
Wang TS; Evans DB; Fareau GG; Carroll T; Yen TW
Ann Surg Oncol; 2012 Dec; 19(13):4217-22. PubMed ID: 23010732
[TBL] [Abstract][Full Text] [Related]
18. Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High-Risk Differentiated Thyroid Cancer: A Phase III, Randomized, Placebo-Controlled Trial (ASTRA).
Ho AL; Dedecjus M; Wirth LJ; Tuttle RM; Inabnet WB; Tennvall J; Vaisman F; Bastholt L; Gianoukakis AG; Rodien P; Paschke R; Elisei R; Viola D; So K; Carroll D; Hovey T; Thakre B; Fagin JA;
J Clin Oncol; 2022 Jun; 40(17):1870-1878. PubMed ID: 35192411
[TBL] [Abstract][Full Text] [Related]
19. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
[TBL] [Abstract][Full Text] [Related]
20. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
